Schulhoff & Co’s GE HealthCare GEHC Stock Holding History

Schulhoff & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,139	Closed	-$201K	–	130
2024 Q3	$201K	Buy	+2,139	New	+$180K	0.08%	126

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Schulhoff & Co's GEHC Position: Q4 2024 in Review

Schulhoff & Co sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,139 shares — an estimated $201K sold.

Schulhoff & Co first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $201K in Q3 2024. 1,324 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Schulhoff & Co reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Schulhoff & Co sold 2,139 GE HealthCare shares in Q4 2024, an estimated $201K.
Schulhoff & Co first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
Schulhoff & Co's GE HealthCare position peaked at $201K in Q3 2024.
1,324 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Schulhoff & Co's 13F filing for Q4 2024, filed 5 Feb 2025.